Duality Advisers, LP Catalent, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$72.36 - $113.1 $230,177 - $359,771	3,181 Added 152.79%	5,263 $381,000
Q2 2022 Aug 08, 2022	BUY	$87.2 - $114.05 $181,550 - $237,452	2,082 New	2,082 $223,000
Q2 2021 Aug 09, 2021	SELL	$100.34 - $115.69 $196,666 - $226,752	-1,960 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $29,945 - $36,954	-295 Reduced 13.08%	1,960 $206,000
Q4 2020 Feb 09, 2021	SELL	$85.88 - $105.36 $409,218 - $502,040	-4,765 Reduced 67.88%	2,255 $235,000
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $510,634 - $649,350	7,020 New	7,020 $601,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.